Delivery Order SPE2DB24D2212-SPE2DB25FHPAU

Award Date 2/24/25
Potential Completion Date 2/25/25
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $5,063.79 firm-fixed-price delivery order is for the supply of 10-unit dosage CLOMID 50 MG TABLET. The award has an ultimate completion date of October 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,242.46 firm-fixed-price delivery order is for the supply of CLOMID 50 MG TABLET UD 30S, a prescription medication. The contract has an ultimate completion date of December 1, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award is a delivery order valued at $5,005.08 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the supply of 4,566,197,338 units of the medication CLOMID 50 MG TABLET UD 30S. The contract has an ultimate completion date of October 25, 2024 and is a firm fixed price agreement. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award is a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $5,298.85 firm-fixed-price contract is for the delivery of CLOMID 50 MG TABLET UD 30S, with a completion date of December 23, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,967.42 firm fixed-price delivery order is for the supply of CLOMID 50 MG TABLET UD 10S, a pharmaceutical product. The contract has an ultimate completion date of March 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,494.77 firm fixed-price delivery order is for the provision of 4565912418 - CLOMID 50 MG TABLET UD 30S. The contract has an ultimate completion date of September 24, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,200.65 Firm Fixed Price delivery order contract is for the supply of CLOMID 50 MG TABLET UD 30S, a generic prescription medication. The contract has an ultimate completion date of November 7, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,224.55, is a delivery order for 4566798954 - CLOMID 50 MG TABLET UD 10S. It is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $12,885.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4566420447 CLOMID 50 MG TABLET UD 30S, with a completion date of November 14, 2024. The contract is a Firm Fixed Price agreement, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $1,360.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CLOMID 50 MG TABLET UD 30S, a pharmaceutical product, with a performance period ending on May 8, 2023. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and there is no set-aside designation. AmerisourceBergen holds a significant...
  • SPE2DB24D2212
    Indefinite Delivery Contract
  • SPE2DB24D2212-SPE2DB25FHPAU
    Delivery Order

This federal contract award is a delivery order valued at $3,115.88 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of CLOMID 50 MG TABLET UD 30S, a medication, with a completion date of February 25, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

The contract award reviewed has no set-aside designation, indicating open competition.

Generated 6/1/25, 3:33 AM